Description: Establishment Labs (ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or a direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implant® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes Divina® 3D Simulation System, Puregraft, and MotivaImage® Centers.
Home Page: www.establishmentlabs.com
ESTA Technical Analysis
Building B15 and 25
Alajuela,
Costa Rica
Phone:
506 2434 2400
Officers
Name | Title |
---|---|
Mr. Juan Jose Chacon Quiros | Founder, CEO & Exec. Director |
Mr. Rajbir Singh Denhoy | Chief Financial Officer |
Mr. Paul D. Rodio | Chief Operating Officer |
Mr. Roberto de Mezerville | Chief Technology Officer |
Mr. S. Ross Mansbach | Gen. Counsel & Chief Compliance Officer |
Mr. Jeffrey Clark Bettinger | Global Head of People |
Mr. Salvador Santos Dada | Chief Operating Officer (Medical Leave of Absence) |
Dr. Heather Brennan | Head of U.S. Commercial Operations |
Ms. Neeta Toprani | Corp. Sec. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Supplies |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1133.3044 |
Price-to-Sales TTM: | 10.6315 |
IPO Date: | 2018-07-19 |
Fiscal Year End: | December |
Full Time Employees: | 746 |